Reduction of cerebellar glucose metabolism in advanced Alzheimer's disease

Journal of Nuclear Medicine

Volumn 38, Issue 6, 1997, Pages 925-928

  Ishii, Kazunari ^a   Sasaki, Masahiro ^b   Kitagaki, Hajime ^b   Yamaji, Shigeru ^b   Sakamoto, Setsu ^b   Matsuda, Kant ^b   Mori, Etsuro ^b  

^a Hyogo Inst Aging Brain Cogn D   (Japan)

^b NONE

Author keywords

Alzheimer's disease; Cerebellum; Cerebral glucose metabolism; Fluorine 18 fluorodeoxyglucose; PET

Indexed keywords

ADULT; AGED; ALZHEIMER DISEASE; ANALYTIC METHOD; ARTICLE; BRAIN BLOOD FLOW; BRAIN MAPPING; BRAIN METABOLISM; COGNITION; FEMALE; GLUCOSE BRAIN LEVEL; GLUCOSE METABOLISM; HUMAN; MAJOR CLINICAL STUDY; MALE; METABOLIC RATE; NEUROPSYCHOLOGY; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

AGED; ALZHEIMER DISEASE; BRAIN; CASE-CONTROL STUDIES; CEREBELLUM; DEOXYGLUCOSE; FEMALE; FLUORINE RADIOISOTOPES; FLUORODEOXYGLUCOSE F18; GLUCOSE; HUMANS; MALE; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0030952709     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Kumar A, Schapiro MB, Grady C, et al. High-resolution PET studies in Alzheimer's disease. Neuropsychopharmacology 1991;4:35-46.
2. Ishii K, Kitagaki H, Kono M, Mori E. Decreased medial temporal oxygen metabolism in Alzheimer's disease shown by PET. J Nucl Med 1996;37:1159-1165.
3. 123I-IMP SPECT. Clin Nucl Med 1996;21:106-110.
4. Yamaguchi H, Hirai S, Morimatsu M, Shoji M, Nakazato Y. Diffuse type of senile plaques in the cerebellum of Alzheimer-type dementia demonstrated by beta protein immunostain. Acta Neuropathol 1989;77:314-319.
5. Cole G, Neal JW, Singhrao SK, Jasani B, Newman GR. The distribution of amyloid plaques in the cerebellum and brain stem in Down's syndrome and Alzheimer's disease: a light microscopical analysis. Acta Neuropathol 1993;85:542-552.
6. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease. Neurology 1984;34:939-944.
7. Morris JC, The clinical dementia rating: current version and screening rules. Neurology 1993;43:2412-2414.
8. Mori E, Mitani Y, Yamadori A. Usefulness of Japanese version of the Mini-Mental State test in neurological patients. Jpn J Neuropsychiatry 1985;1:82-90.
9. Honma A, Fukuzawa K, Tsukada Y, Ishii T, Hasegawa K, Mohs RC. Development of a Japanese version of Alzheimer's disease assessment scale. Jpn J Geriatr Psychiatry 1992;647-655.
10. Ishii K, Sasaki M, Sakamoto S, Kitagaki H, Yamaji S, Maeda K. Regional difference of cerebral blood flow and oxidative metabolism in human cortex. J Nucl Med 1996;37:1086-1088.
11. Iida H, Miura S, Kanno I, et al. Design of evaluation of Headtome IV: a whole-body PET. IEEE Trans Nucl Sci 1989;NS-37:1006-1010.
12. Talairach J, Tournoux P. Co-planar stereotaxic atlas of the human brain. Stuttgart. Germany: Thieme Verlag; 1988.
13. 14C-deoxyglucose method for the measurement of local cerebral glucose utilization, theory, procedure and normal values in the conscious and anesthetized albino rat. J Neurochem 1977;28:897-916.
14. 18F]-2-fluoro-2-deoxy-D-glucose: validation of method. Ann Neurol 1979;6:371-388.
15. 11C-deoxyglucose. J Cereb Blood Flow Metab 1985;5:179-192.
16. Cutler NR, Haxby JV, Duara R, et al. Clinical history, brain metabolism and neuropsychological function in Alzheimer's disease. Ann Neurol 1985;18:298-309.
17. 11C-deoxyglucose accumulation, CSF monoamine metabolites and neuropsychological test performance in patients and healthy subjects. J Neurol Neurosurg Psychiatry 1991;54:672-678.
18. Kushner M, Tobin M, Alavi A, et al. Cerebellar glucose consumption in normal and pathologic states using fluorine-FDG and PET. J Nucl Med 1987;28:1667-1670.
19. Blin J, Baron JC, Dubois B, et al. Positron emission tomography study in progressive supranuclear palsy. Brain hypometabolic pattern and clinicometabolic correlations. Arch Neurol 1990;47:747-752.
20. Akiyama H, Harrop R, McGeer PL, Peppard R, McGeer EG. Crossed cerebellar and uncrossed basal ganglia and thalamic diaschisis in Alzheimer's disease. Neurology 1989;45:191-206.
21. Claus JJ, van Harskamp F, Breteler MM, et al. Assessment of cerebral perfusion with single-photon emission tomography in normal subjects and in patients with Alzheimer's disease: effect of region of interest selection. Eur J Nucl Med 1994;21:1044-1051.
22. Talbot PR, Lloyd JJ, Snowden JS, Neary D, Testa HJ. Choice of reference region in the quantification of single-photon emission tomography in primary degenerative dementia. Eur J Nucl Med 1994;21:503-508.
23. Lou HC, Edwinsson L, MacKenzie ET, The coupling blood flow to brain function: revision required? Ann Neurol 1987;22:289-297.
24. Buckner RL, Petersen SE, Ojemann JG, Miezin FM, Squire LR, Raichle ME. Functional anatomical studies of explicit and implicit memory retrieval tasks. J Neurasci 1995;15:12-29.